Literature DB >> 11507359

The effect of a lactose-restricted diet in patients with a positive lactose tolerance test, earlier diagnosed as irritable bowel syndrome: a 5-year follow-up study.

C J Böhmer1, H A Tuynman.   

Abstract

DESIGN AND METHODS: Prospectively, the effect of a lactose-restricted diet was evaluated among irritable bowel syndrome patients with lactose malabsorption. Lactose malabsorption was defined by a positive hydrogen breath test and a positive blood-glucose test. An analysis of symptoms was completed before, during, 6 weeks after and 5 years after starting the diet. In addition, the number of visits made by the patients to the outpatient clinic was scored during 6 years.
RESULTS: In 17 out of 70 irritable bowel syndrome patients (24.3%), lactose malabsorption was detected. There was no difference in the symptom score between patients with a positive lactose tolerance test and patients with a negative lactose tolerance test. After 6 weeks of the lactose-restricted diet, symptoms were markedly improved in lactose malabsorption-positive patients (P < 0.001). After 5 years, one patient was lost for follow-up, and 14 out of the remaining 16 lactose malabsorption patients (87.5%) still had no complaints during the lactose-restricted diet. Two patients chose not to follow the diet continuously and accepted the discomfort caused by lactose intake. Only two out of 16 patients (12.5%) no longer experienced any benefit from lactose restriction. In the 5 years before their diagnosis of lactose malabsorption, these 16 patients visited the outpatient clinic a total of 192 times (mean 2.4 visits per year per person; range 1-7 visits). In the 5 years after diagnosis, they visited the outpatient clinic a total of 45 times (mean 0.6 visits per year per person; range 0-6 visits; P < 0.0001).
CONCLUSIONS: In a large majority of irritable bowel syndrome patients with lactose malabsorption, which was previously clinically unrecognized, a lactose-restricted diet improved symptoms markedly both in the short term and the long term. Furthermore, visits by all patients to the outpatient clinic were reduced by 75%. We conclude that diet therapy is extremely cost- and time-saving. Therefore, it is strongly recommended that lactose malabsorption, which is easily treatable, is excluded before diagnosing irritable bowel syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11507359     DOI: 10.1097/00042737-200108000-00011

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  27 in total

1.  The treatment of irritable bowel syndrome.

Authors:  Brian E Lacy; Kirsten Weiser; Ryan De Lee
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

Review 2.  Systemic lactose intolerance: a new perspective on an old problem.

Authors:  S B Matthews; J P Waud; A G Roberts; A K Campbell
Journal:  Postgrad Med J       Date:  2005-03       Impact factor: 2.401

Review 3.  Differential diagnosis between functional and organic intestinal disorders: is there a role for non-invasive tests?

Authors:  Francesco Costa; Maria Gloria Mumolo; Santino Marchi; Massimo Bellini
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

4.  Molecularly defined adult-type hypolactasia among working age people with reference to milk consumption and gastrointestinal symptoms.

Authors:  Sari R Anthoni; Heli A Rasinperä; Antti J Kotamies; Hanna A Komu; Harri K Pihlajamäki; Kaija Leena Kolho; Irma E Järvelä
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

Review 5.  Lactase Non-persistence and Lactose Intolerance.

Authors:  Theodore M Bayless; Elizabeth Brown; David M Paige
Journal:  Curr Gastroenterol Rep       Date:  2017-05

6.  Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome.

Authors:  Piero Portincasa; Antonio Moschetta; Giuseppe Baldassarre; Donato F Altomare; Giuseppe Palasciano
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

7.  Dietary Renaissance in IBS: Has Food Replaced Medications as a Primary Treatment Strategy?

Authors:  Marisa Spencer; William D Chey; Shanti Eswaran
Journal:  Curr Treat Options Gastroenterol       Date:  2014-12

8.  Lactose malabsorption and intolerance: pathogenesis, diagnosis and treatment.

Authors:  Benjamin Misselwitz; Daniel Pohl; Heiko Frühauf; Michael Fried; Stephan R Vavricka; Mark Fox
Journal:  United European Gastroenterol J       Date:  2013-06       Impact factor: 4.623

Review 9.  Use and abuse of hydrogen breath tests.

Authors:  M Simrén; P-O Stotzer
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

10.  Irritable bowel syndrome: the role of food in pathogenesis and management.

Authors:  Paula A Hayes; Marianne H Fraher; Eamonn M M Quigley
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.